U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Abdun-Nabi Daniel (0001380187)
Mailing Address
400 PROFESSIONAL DRIVE
SUITE 400
GAITHERSBURG MD 20879
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Aptevo Therapeutics Inc. 0001671584 2024-06-01 director
REGENXBIO Inc. 0001590877 2016-08-05 director
Emergent BioSolutions Inc. 0001367644 2010-03-09 director, officer: President & COO


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-07-17   Aptevo Therapeutics Inc. 4 A-Award --D 925.0000 925.0000 1 0001671584 Restricted Stock Unit
D 2024-06-02   Aptevo Therapeutics Inc. 4 M-Exempt --D 81.0000 0.0000 4 0001671584 Restricted Stock Unit
A 2024-06-02   Aptevo Therapeutics Inc. 4 M-Exempt --D 81.0000 277.0000 2 0001671584 Common Stock
D 2024-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 7.0000 0.0000 3 0001671584 Restricted Stock Unit
A 2024-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 7.0000 196.0000 1 0001671584 Common Stock
D 2023-08-09   Aptevo Therapeutics Inc. 4 M-Exempt --D 3571.0000 0.0000 2 0001671584 Restricted Stock Unit
A 2023-08-09   Aptevo Therapeutics Inc. 4 M-Exempt --D 3571.0000 8339.0000 1 0001671584 Common Stock
A 2023-06-02   Aptevo Therapeutics Inc. 4 A-Award --D 3571.0000 3571.0000 3 0001671584 Restricted Stock Unit
D 2023-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 297.0000 298.0000 2 0001671584 Restricted Stock Unit
A 2023-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 297.0000 4768.0000 1 0001671584 Common Stock
A 2022-08-09   Aptevo Therapeutics Inc. 4 A-Award --D 3571.0000 3571.0000 1 0001671584 Restricted Stock Unit
D 2022-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 298.0000 595.0000 2 0001671584 Restricted Stock Unit
A 2022-06-01   Aptevo Therapeutics Inc. 4 M-Exempt --D 298.0000 8108.0000 1 0001671584 Common Stock
A 2021-06-04   REGENXBIO Inc. 4 A-Award --D 10000.0000 10000.0000 1 0001590877 Stock Option (Right to Buy)
A 2021-06-01   Aptevo Therapeutics Inc. 4 A-Award --D 893.0000 893.0000 2 0001671584 Restricted Stock Unit
A 2021-06-01   Aptevo Therapeutics Inc. 4 A-Award --D 2678.0000 2678.0000 1 0001671584 Stock Option (right to buy)
A 2020-07-27   Aptevo Therapeutics Inc. 4 A-Award --D 170.0000 170.0000 5 0001671584 Stock Option (right to buy)
A 2020-07-27   Aptevo Therapeutics Inc. 4 A-Award --D 1322.0000 1322.0000 4 0001671584 Stock Option (right to buy)
D 2020-07-27   Aptevo Therapeutics Inc. 4 D-Return --D 1785.0000 0.0000 3 0001671584 Stock Option (right to buy)
D 2020-07-27   Aptevo Therapeutics Inc. 4 D-Return --D 892.0000 0.0000 2 0001671584 Stock Option (right to buy)
D 2020-07-27   Aptevo Therapeutics Inc. 4 D-Return --D 1339.0000 0.0000 1 0001671584 Stock Option (right to buy)
A 2020-07-02   Aptevo Therapeutics Inc. 4 A-Award --D 3571.0000 3571.0000 1 0001671584 Stock Option (right to buy)
A 2020-05-29   REGENXBIO Inc. 4 A-Award --D 10000.0000 10000.0000 1 0001590877 Stock Option (Right to Buy)
A 2019-06-25   Aptevo Therapeutics Inc. 4 P-Purchase --D 16667.0000 109351.0000 1 0001671584 Common Stock
A 2019-06-01   Aptevo Therapeutics Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001671584 Option (right to buy)
A 2019-05-31   REGENXBIO Inc. 4 A-Award --D 10000.0000 10000.0000 1 0001590877 Stock Option (Right to Buy)
D 2019-03-04   Emergent BioSolutions Inc. 4 S-Sale --D 14565.0000 142617.0000 1 0001367644 Common Stock
D 2019-02-28   Emergent BioSolutions Inc. 4 F-InKind --D 5101.0000 157182.0000 3 0001367644 Common Stock
D 2019-02-27   Emergent BioSolutions Inc. 4 F-InKind --D 2570.0000 162283.0000 2 0001367644 Common Stock
D 2019-02-26   Emergent BioSolutions Inc. 4 F-InKind --D 1714.0000 164853.0000 1 0001367644 Common Stock
A 2018-09-17   Emergent BioSolutions Inc. 4 M-Exempt --D 1319.0000 0.0000 7 0001367644 Stock Option (Right to Buy)
D 2018-09-17   Emergent BioSolutions Inc. 4 S-Sale --D 1319.0000 166567.0000 4 0001367644 Common Stock
A 2018-09-17   Emergent BioSolutions Inc. 4 M-Exempt --D 1319.0000 167886.0000 3 0001367644 Common Stock
A 2018-09-14   Emergent BioSolutions Inc. 4 M-Exempt --D 28220.0000 1319.0000 6 0001367644 Stock Option (Right to Buy)
D 2018-09-14   Emergent BioSolutions Inc. 4 S-Sale --D 28220.0000 166567.0000 2 0001367644 Common Stock
A 2018-09-14   Emergent BioSolutions Inc. 4 M-Exempt --D 28220.0000 194787.0000 1 0001367644 Common Stock
D 2018-09-05   Emergent BioSolutions Inc. 4 S-Sale --D 30776.0000 166567.0000 3 0001367644 Common Stock
D 2018-09-04   Emergent BioSolutions Inc. 4 M-Exempt --D 60000.0000 29539.0000 5 0001367644 Stock Option (Right to Buy)
D 2018-09-04   Emergent BioSolutions Inc. 4 S-Sale --D 60000.0000 197343.0000 2 0001367644 Common Stock
A 2018-09-04   Emergent BioSolutions Inc. 4 M-Exempt --D 60000.0000 257343.0000 1 0001367644 Common Stock
D 2018-06-05   Emergent BioSolutions Inc. 4 S-Sale --D 15785.0000 197343.0000 1 0001367644 Common Stock
A 2018-06-01   Aptevo Therapeutics Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001671584 Stock Option (right to buy)
A 2018-05-25   REGENXBIO Inc. 4 A-Award --D 12500.0000 12500.0000 1 0001590877 Stock Option (Right to Buy)
D 2018-03-09   Emergent BioSolutions Inc. 4 F-InKind --D 7825.0000 213128.0000 1 0001367644 Common Stock
D 2018-02-28   Emergent BioSolutions Inc. 4 F-InKind --D 6599.0000 220953.0000 4 0001367644 Common Stock
A 2018-02-27   Emergent BioSolutions Inc. 4 A-Award --D 53485.0000 53485.0000 6 0001367644 Employee Stock Option (right to buy)
D 2018-02-27   Emergent BioSolutions Inc. 4 F-InKind --D 3324.0000 227552.0000 3 0001367644 Common Stock
A 2018-02-27   Emergent BioSolutions Inc. 4 A-Award --D 13371.0000 230876.0000 2 0001367644 Common Stock
A 2018-02-27   Emergent BioSolutions Inc. 4 A-Award --D 13371.0000 217505.0000 1 0001367644 Common Stock
D 2018-01-02   Emergent BioSolutions Inc. 4 M-Exempt --D 21906.0000 0.0000 4 0001367644 Stock Option (Right to Buy)
D 2018-01-02   Emergent BioSolutions Inc. 4 S-Sale --D 21906.0000 204134.0000 2 0001367644 Common Stock
A 2018-01-02   Emergent BioSolutions Inc. 4 M-Exempt --D 21906.0000 226040.0000 1 0001367644 Common Stock
D 2017-12-13   Emergent BioSolutions Inc. 4 M-Exempt --D 20000.0000 21906.0000 4 0001367644 Stock Option (Right to Buy)
D 2017-12-13   Emergent BioSolutions Inc. 4 S-Sale --D 20000.0000 204134.0000 2 0001367644 Common Stock
A 2017-12-13   Emergent BioSolutions Inc. 4 M-Exempt --D 20000.0000 224134.0000 1 0001367644 Common Stock
D 2017-11-03   Emergent BioSolutions Inc. 4 M-Exempt --D 20000.0000 41906.0000 7 0001367644 Stock Option (Right to Buy)
D 2017-11-03   Emergent BioSolutions Inc. 4 M-Exempt --D 11508.0000 0.0000 6 0001367644 Stock Option (Right to Buy)
D 2017-11-03   Emergent BioSolutions Inc. 4 S-Sale --D 20000.0000 204134.0000 4 0001367644 Common Stock
A 2017-11-03   Emergent BioSolutions Inc. 4 M-Exempt --D 20000.0000 224134.0000 3 0001367644 Common Stock
D 2017-11-03   Emergent BioSolutions Inc. 4 S-Sale --D 11508.0000 204134.0000 2 0001367644 Common Stock
A 2017-11-03   Emergent BioSolutions Inc. 4 M-Exempt --D 11508.0000 215642.0000 1 0001367644 Common Stock
A 2017-09-27   Emergent BioSolutions Inc. 4 M-Exempt --D 15000.0000 219134.0000 1 0001367644 Common Stock
D 2017-09-27   Emergent BioSolutions Inc. 4 S-Sale --D 15000.0000 204134.0000 2 0001367644 Common Stock
D 2017-09-27   Emergent BioSolutions Inc. 4 M-Exempt --D 15000.0000 11508.0000 4 0001367644 Stock Option (Right to Buy)
D 2017-08-31   Emergent BioSolutions Inc. 4 M-Exempt --D 15000.0000 26508.0000 3 0001367644 Stock Option (Right to Buy)
D 2017-08-31   Emergent BioSolutions Inc. 4 S-Sale --D 15000.0000 204134.0000 2 0001367644 Common Stock
A 2017-08-31   Emergent BioSolutions Inc. 4 M-Exempt --D 15000.0000 219134.0000 1 0001367644 Common Stock
A 2017-06-01   Aptevo Therapeutics Inc. 4 A-Award --D 12500.0000 12500.0000 1 0001671584 Employee Stock Option (right to buy)
A 2017-05-24   REGENXBIO Inc. 4 A-Award --D 12500.0000 12500.0000 1 0001590877 Stock Option (Right to Buy)
D 2017-03-10   Emergent BioSolutions Inc. 4 F-InKind --D 10738.0000 204134.0000 2 0001367644 Common Stock
D 2017-03-09   Emergent BioSolutions Inc. 4 F-InKind --D 8226.0000 214872.0000 1 0001367644 Common Stock
A 2017-02-28   Emergent BioSolutions Inc. 4 A-Award --D 78329.0000 78329.0000 4 0001367644 Employee Stock Option (right to buy)
D 2017-02-28   Emergent BioSolutions Inc. 4 F-InKind --D 6184.0000 223098.0000 3 0001367644 Common Stock
A 2017-02-28   Emergent BioSolutions Inc. 4 A-Award --D 19589.0000 229282.0000 2 0001367644 Common Stock
A 2017-02-28   Emergent BioSolutions Inc. 4 A-Award --D 19588.0000 209693.0000 1 0001367644 Common Stock
A 2017-02-27   Emergent BioSolutions Inc. 4 M-Exempt --D 3662.0000 192824.0000 1 0001367644 Common Stock
D 2017-02-27   Emergent BioSolutions Inc. 4 F-InKind 1-D 1735.0000 191089.0000 2 0001367644 Common Stock
D 2017-02-27   Emergent BioSolutions Inc. 4 M-Exempt --D 3662.0000 0.0000 4 0001367644 Stock Option - (Right to Buy)
D 2017-02-27   Emergent BioSolutions Inc. 4 F-InKind --D 984.0000 190105.0000 3 0001367644 Common Stock
A 2017-01-10   Emergent BioSolutions Inc. 4 M-Exempt --D 38006.0000 3662.0000 7 0001367644 Stock Option (Right to buy)

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016